Cetera Investment Advisers’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $171K | Sell |
14,753
-9,238
| -39% | -$107K | ﹤0.01% | 3763 |
|
2025
Q1 | $209K | Buy |
23,991
+4,093
| +21% | +$35.7K | ﹤0.01% | 3571 |
|
2024
Q4 | $286K | Buy |
19,898
+3,679
| +23% | +$52.8K | ﹤0.01% | 3154 |
|
2024
Q3 | $366K | Buy |
16,219
+5,453
| +51% | +$123K | ﹤0.01% | 2901 |
|
2024
Q2 | $209K | Buy |
10,766
+2,289
| +27% | +$44.5K | ﹤0.01% | 3329 |
|
2024
Q1 | $318K | Buy |
+8,477
| New | +$318K | ﹤0.01% | 2980 |
|
2022
Q1 | – | Sell |
-1,439
| Closed | -$214K | – | 1984 |
|
2021
Q4 | $214K | Buy |
+1,439
| New | +$214K | ﹤0.01% | 1695 |
|